Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: Results from the Global Burden of Disease Study 2017

184Citations
Citations of this article
169Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims: To estimate the prevalence, incidence, mortality, and risk factors for atrial fibrillation (AF) in 195 countries and territories from 1990 to 2017. Methods and results: Following the methodologies used in the Global Burden of Disease Study 2017, the prevalence, incidence, and mortality of AF were analysed by age, sex, year, socio-demographic index (SDI), and location. The percentage contributions of major risk factors to age-standardized AF deaths were measured by population attributable fractions. In 2017, there were 37.57 million [95% uncertainty interval (UI) 32.55-42.59] prevalent cases and 3.05 million (95% UI 2.61-3.51) incident cases of AF globally, contributing to 287 241 (95% UI 276 355-304 759) deaths. The age-standardized rates of prevalent cases, incident cases, and deaths of AF in 2017 and their temporal trends from 1990 to 2017 varied significantly by SDI quintile and location. High systolic blood pressure was the leading risk factor for AF age-standardized deaths [34.3% (95% UI 27.4-41.5)] in 2017, followed by high body mass index [20.7% (95% UI 11.5-32.2)] and alcohol use [9.4% (95% UI 7.0-12.2)]. Conclusion: Our study has systematically and globally assessed the temporal trends of AF, which remains a major public heath challenge. Although AF mainly occurred in developed countries, the unfavourable trend in countries with lower SDI also deserves particular attention. More effective prevention and treatment strategies aimed at counteracting the increase in AF burden should be established in some countries.

References Powered by Scopus

Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017

9943Citations
N/AReaders
Get full text

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

5742Citations
N/AReaders
Get full text

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials

4165Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The changing landscape of atherosclerosis

1435Citations
N/AReaders
Get full text

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

776Citations
N/AReaders
Get full text

European Society of Cardiology: cardiovascular disease statistics 2021

615Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Dai, H., Zhang, Q., Much, A. A., Maor, E., Segev, A., Beinart, R., … Wu, J. (2021). Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: Results from the Global Burden of Disease Study 2017. European Heart Journal - Quality of Care and Clinical Outcomes, 7(6), 574–582. https://doi.org/10.1093/ehjqcco/qcaa061

Readers over time

‘20‘21‘22‘23‘24‘25015304560

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 41

72%

Researcher 13

23%

Professor / Associate Prof. 3

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 39

76%

Pharmacology, Toxicology and Pharmaceut... 5

10%

Nursing and Health Professions 4

8%

Engineering 3

6%

Article Metrics

Tooltip
Mentions
References: 1

Save time finding and organizing research with Mendeley

Sign up for free
0